Organisation paid for research Program year 2021 Source: CMS Open Payments

Burke Primary Care

Neither a doctor nor a teaching hospital

Research payments

$236,618

10 payments

Through program year 2021, Burke Primary Care is reported as receiving $236,618 in research payments, across 10 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$221,572	6
2020	Research	$3,125	2
2019	Research	$11,922	2

Breakdown

Who paid Research payments · program years 2019–2021

Abbott Laboratories $213,500 1 payment
Ironwood Pharmaceuticals, Inc $11,922 2 payments
Eli Lilly and Company $11,196 7 payments

Studies the money was for Research payments · program years 2019–2021

Clinical Evaluation of the Investigational ID NOW COVID-19 Assay $213,500 1 payment
Rdea594-401 $11,922 2 payments
A Phase 2, Parallel, Comparator Controlled Trial to Evaluate the Safety and Efficacy of Ly3209590 in Insulin Naive Patients With Type 2 Diabetes Mellitus $10,715 3 payments
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly As Add-On Therapy to Metformin in Patients With Type 2 Diabetes $321 1 payment
A Study of Tirzepatide (Ly3298176) Once A Week Versus Insulin Glargine Once A Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk $65 1 payment
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the Rebuild Study $50 1 payment
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe Alopecia Areata $46 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.